StayCurrentMD · Best of the Best in Pediatric Surgery Winner Announcement
Follow
Video8 min·Published Apr 2022Older

Best of the Best in Pediatric Surgery Winner Announcement

With Dr. Kasir Collaj

Chapter 1 of 4 · Fundamentals

Event introduction

Introduction to Best of the Best Event

Try
Intelligent Search· scoped to congenital diaphragmatic hernia · not medical adviceSearch the whole library →
Only a few other public items share this expert — go deeper there →
What the experts said16 expert statements · 1 host summary
Congenital diaphragmatic hernia is characterized by impaired fetal lung growth and maturation
ClinicalKasir Collaj
CDH has unacceptably high mortality and morbidity rates
EpidemiologicalKasir Collaj
One of the biggest challenges for babies with CDH is that fetal hypoplastic lungs are immature with impairment of cell differentiation, especially in the epithelium
ClinicalKasir Collaj
Extracellular vesicles (EVs) are the main mediators of stem cell paracrine signaling
ClinicalKasir Collaj
Amniotic fluid stem cell derived EVs can rescue fetal lung growth and maturation in several models of CDH at the pseudoglandular stage
ClinicalKasir Collaj
The pseudoglandular stage corresponds to 7 to 16 weeks of human gestation
ClinicalKasir Collaj
CDH is diagnosed around 18 to 20 weeks gestation
ClinicalKasir Collaj
The canalicular and saccular stages are translationally relevant developmental stages where intervention is possible for CDH
ClinicalKasir Collaj
The nitrophin model is a well-established model for studying CDH, created by administering the herbicide nitrophin to pregnant rat dams at embryonic day 9.5
ClinicalKasir Collaj
Hypoplastic lungs at canalicular and saccular stages show down-regulation of alveolar type 1 and 2 cells, as well as basal and club cells compared to control
ClinicalKasir Collaj
Treatment of hypoplastic lungs with amniotic fluid stem cell derived extracellular vesicles restores primary markers of alveolar type 1 and 2 cells, basal cells, and club cells, indicating cell homeostasis can be achieved
ClinicalKasir Collaj
In vivo experiments have been performed looking at different administration routes including intraamniotic and tracheal routes for extracellular vesicles
ClinicalKasir Collaj
Results from in vivo administration of extracellular vesicles are quite promising
ClinicalKasir Collaj
Collaboration with Dr. Jan De Prest is underway to look at safety and feasibility of AFSC-EV treatment in a lab model
ClinicalKasir Collaj
The lack of ciliated cell rescue may be due to an imbalance of different cell types in the hypoplastic fetal lung, with the treatment achieving overall cell homeostatic balance rather than rescuing every specific cell type
ClinicalKasir Collaj
Key markers expressed in branching morphogenesis are being rescued effectively with AFSC-EV treatment
ClinicalKasir Collaj
No difference was found in ciliated cells with AFSC-EV treatment
Host summaryThe host summarizing the discussion · not cited in answers